Adimab vs Khosen Bio
Adimab vs Khosen Bio, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adimab is on 53/100 and Khosen Bio on 35/100.
Where each one leads
Adimab
- our overall score: 53/100 against 35/100
- agent readiness: 40/100 against 35/100
Khosen Bio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Adimab | Khosen Bio |
|---|---|---|
| What it is | Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform. | Developing novel therapeutic antibodies for challenging diseases. |
| Category | Biotech, Drug Discovery, Antibody Discovery, Therapeutic Antibodies | Biotech, Drug Discovery, Therapeutics, Antibody Engineering |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2007 | 2017 |
| Headquarters | Lebanon, United States | ירושלים, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Adimab | Khosen Bio |
|---|---|---|
| Employees | 139 | Not published |
| Total funding | $105M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 8,423 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adimab | Khosen Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 35/100 |
| Traction | 60/100 | Not published |
| Team | Not published | 60/100 |
| Community | Not published | 15/100 |
| Search visibility | 20/100 | 15/100 |
| Quality | 68/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 39/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adimab | Khosen Bio |
|---|---|---|
| Hosting | AWS | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Tag Manager, Linkedin Insight | Not detected |
| Support stack | HubSpot | Not detected |
| Open source | No | Yes |
Adimab vs Khosen Bio: common questions
Which is better, Adimab or Khosen Bio?
On our 0-100 score Adimab rates higher (53/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Adimab and Khosen Bio compare on the numbers?
Adimab leads on our overall score (53/100 against 35/100), agent readiness (40/100 against 35/100).
Read the full Adimab review and pricing or the Khosen Bio review and pricing. You can also browse other Adimab alternatives we track.